--- the subscriber area has no ads and those above are not selected or endorsed by this site ---
Resonant 3Q17 report ?3
18:27 08-Nov-17
Resonant's conference call has just concluded. With regard to
the question of management's attitude to activist investors,
comments that it "will not be distracted" give a pretty clear
implication. In light of that, costs and further dilution become
more important. The company used $3.1M last quarter, which is
down from a $3.5-4M run rate, but OpEx will tick back up towards
the average going forward. That means there are already funds on
the balance sheet (though not in the filings, as funds from the
most recent raise came in after the quarter's end) to support
operations through the second half of next year.
Against that is the fact that the latest part has been sampling
for over a month. That means that design-in could occur by year
end, putting management in a position to quantify some recurring
revenue on the next call. Overall, Resonant's TAM for designs
already under contract is now up to 380-390M devices, for $42M of
potential licensing revenue. Looking further out, cheaper
quadplexers mean the carrier aggregation market share in China can
go from 15 to 50%, so we should continue to see strong growth. In
conjunction with that, management was at pains to point out that
the center that it is opening in China is for sales and support,
rather than design, so the company's intellectual property will
supposedly not be at risk. Initial projections are for the center
to be operating in the 1st quarter of next year.
On 11/08/2017 04:13 PM, Esekla wrote:
Resonant has announced results for its third quarter:
- a loss of 28 cents per share is in-line
- on $106K of revenue, which misses by $104K
I will prioritize the CenturyLink call over Resonant's, which occurs at the same time.